Browsing: PFENYSE
BeritKPfizer (NYSE:PFE) and GSK (NYSE:GSK) on Thursday agreed to end a patent lawsuit over claims that the former’s vaccine, Abrysvo…
JHVEPhoto/iStock Editorial via Getty ImagesPfizer (NYSE:PFE) has generated £2.5B ($3.24B) after selling its entire stake in Haleon (NYSE:HLN), the consumer…
JHVEPhoto/iStock Editorial via Getty Images Pfizer (NYSE:PFE) is planning to sell 662M shares of Haleon (NYSE:HLN) to divest its remaining…
David Dee DelgadoPfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big…
Alexandros MichailidisPfizer (NYSE:PFE) has decided to end R&D and marketing activities related to Beqvez, a one-time gene therapy the company…
Massimo Giachetti The U.S. FDA has granted an additional approval for Pfizer’s (NYSE:PFE) antibody-drug conjugate Adcetris (brentuximab vedotin), this time…
mesh cube The European Medicine Agency’s Commitee for Medicinal Products for Human Use has issued a positive opinion on Pfizer’s…
Md Saiful Islam KhanPfizer (NYSE:PFE) announced Saturday that its colorectal cancer therapy Braftovi, as part of a combination regimen, reduced…
georgeclerkPfizer (NYSE:PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to physicians to…
Jeenah Moon/Getty Images NewsPfizer (NYSE:PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon (NYSE:HLN) to lower…